Treatment of toxoplasmic lymphadenitis with co-trimoxazole: Double-blind, randomized clinical trial

International Journal of Infectious Diseases

Volumn 14, Issue SUPPL. 3, 2010, Pages

  Alavi, Seyed Mohammad ^a   Alavi, Leila ^b  

^a AHVAZ JUNDISHAPUR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID CHAMRAN UNIVERSITY OF AHVAZ   (Iran)

Author keywords

Co trimoxazole; Lymphadenitis; Toxoplasmosis

Indexed keywords

COTRIMOXAZOLE; IMMUNOGLOBULIN M; PLACEBO;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; FOLLOW UP; HUMAN; LYMPH NODE; LYMPHADENITIS; MALE; RANDOMIZED CONTROLLED TRIAL; TOXOPLASMIC LYMPHADENITIS; TOXOPLASMOSIS; TREATMENT RESPONSE;

ADOLESCENT; AMBULATORY CARE FACILITIES; ANTIPROTOZOAL AGENTS; CHILD; CHILD, PRESCHOOL; DOUBLE-BLIND METHOD; FEMALE; HUMANS; IRAN; LYMPHADENITIS; MALE; TOXOPLASMOSIS; TREATMENT OUTCOME; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION; YOUNG ADULT;

EID: 77957353056     PISSN: 12019712     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijid.2009.11.015     Document Type: Article

References (14)

1. Pasternack M.S., Swartz M.N. Lymphadenitis and lymphangitis. Principles and practice of infectious diseases 2005, 1204-1215. Churchill Livingstone, Philadelphia. 6th ed. G.L. Mandell, J.E. Bennett, R. Dolin (Eds.).
2. McCabe R.E., Brooks R.G., Dorfman R.F., Remington J.S. Clinical spectrum in 107 cases of toxoplasmosis lymphadenopathy. Rev Infect Dis 1987, 9:754-774.
3. Montoya J.G., Kovacs J.A., Remington J.S. Toxoplasma gondii. Principles and practice of infectious diseases 2005, 3170-3198. Churchill Livingstone, Philadelphia. 6th ed. G.L. Mandell, J.E. Bennett, R. Dolin (Eds.).
4. Montoya J.G., Berry A., Rosso F., Remington J.S. The differential agglutination test as a diagnostic aid in cases of toxoplasmic lymphadenitis. J Clin Microbiol 2007, 45:1463-1468.
5. Oluwole S.F., Odesanmi W.O., Kalidasa A.M. Peripheral lymphadenopathy in Nigeria. Acta Trop 1985, 42:87-96.
6. Eapen M., Mathew C.F., Aravindan K.P. Evidence based criteria for the histopathological diagnosis of toxoplasmic lymphadenopathy. Clin Pathol 2005, 58:1143-1146.
7. Durlach R.A., Kaufer F., Carral L., Hirt J. Toxoplasmic lymphadenitis-clinical and serologic profile. Clin Microbiol Infect 2003, 9:625-631.
8. Montoya J.G., Remington J.S. Studies on the serodiagnosis of toxoplasmic lymphadenitis. Clin Infect Dis 1995, 20:781-789.
9. Ahmad M., Iqbal J., Mansoor A., Khan A.H. Toxoplasmic lymphadenitis-a clinicopathological study. J Pak Med Assoc 1991, 41:303-305.
10. Francis P., Patel V.B., Bill P.L., Bhigjee A.I. Oral trimethoprim-sulfamethoxazole in the treatment of cerebral toxoplasmosis in AIDS patients-a prospective study. S Afr Med J 2004, 94:51-53.
11. Arens J., Barnes K., Crowley N., Maartens G. Treating AIDS-associated cerebral toxoplasmosis-pyrimethamine plus sulfadiazine compared with cotrimoxazole, and outcome with adjunctive glucocorticoids. S Afr Med J 2007, 97:956-958.
12. Soheilian M., Sadoughi M.M., Ghajarnia M., Dehghan M.H., Yazdani S., Behboudi H., et al. Prospective randomized trial of trimethoprim/sulfamethoxazole versus pyrimethamine and sulfadiazine in the treatment of ocular toxoplasmosis. Ophthalmology 2005, 12:1876-1882.
13. Grossman P.L., Remington J.S. The effect of trimethoprim/sulfamethoxazole on Toxoplasma gondii in vitro and in vivo. Am J Trop Med Hyg 1979, 28:445-455.
14. Moher D., Schulz K.F., Altman D.G. The CONSORT statement: revised recommendation for improving the quality of reports of parallel-group randomized trials. Lancet 2001, 357:1191-1194.